| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +52% |
| 3Y CAGR | +16% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +111% |
| 3Y CAGR | +39% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,638.00 +10.40 (0.22%) | 21,168.16 | 28.79 | 5.04 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,806.00 +85.50 (3.14%) | 20,634.90 | 30.43 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,936.00 +68.00 (0.99%) | 17,175.63 | 101.26 | 19.68 | ||
Natco PharmaNATCOPHARM | ₹838.75 -4.50 (0.53%) | 15,100.75 | 13.19 | 1.64 |